Diabetes is a chronic condition caused by the body’s inability to produce or make use of insulin
Disease awareness section where you can access information and resources to educate and motivate people living with diabetes
Obesity has been recognised by health organisations including the WHO as a chronic disease that requires long-term management
Haemophilia is an inherited (congenital) bleeding disorder that affects males
Growth Hormone is crucial to the healthy development and functioning of the human body
HRT is used to treat climacteric symptoms of women in different stages of the menopause
Board of Directors and Executive Management
How we are managed, directed and controlled
Semaglutide superior to dulaglutide on glucose control and weight loss in people ... Read more
Changes in Novo Nordisk Executive Management ... Read more
Novo Nordisk increased reported operating profit by 8% in the first six months o ... Read more
Novo Nordisk A/S: Victoza® has been approved in the EU as the only GLP-1 with a ... Read more
Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more
Novo Nordisk A/S - Share repurchase programme ... Read more
Ex-dividend,
Record date,
Interim dividend payment, B shares,
Deutsche Bank Scandinavian Corporate Days, Helsinki
Take an advanced view of the Novo Nordisk share
ADA 2017 investor presentation and webcast
Q2 2017 conference call and roadshow presentation
Read about Novo Nordisk – A focused healthcare company
See relevant content for private investors
Download relevant Investor Relations material
Peter Hugreffe AnkersenHead of Investor Relations
Hanna Ögren Investor Relations Manager
Anders Mikkelsen Investor Relations Manager
Kasper Veje Associate Director IR, North America
Chilie Thomsen Investor Relations Coordinator
Sign up to receive company announcements.
LEADER AdCom conference call and presentation
